$2.04
6.81%
Nasdaq, Jul 03, 07:00 pm CET
ISIN
US8723811084
Symbol
TELA

TELA Bio Inc Stock price

$2.04
+0.47 29.94% 1M
-0.87 29.90% 6M
-0.98 32.45% YTD
-2.31 53.10% 1Y
-5.32 72.28% 3Y
-11.61 85.05% 5Y
-11.31 84.72% 10Y
-11.31 84.72% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
+0.13 6.81%
ISIN
US8723811084
Symbol
TELA
Sector

Key metrics

Basic
Market capitalization
$80.7m
Enterprise Value
$79.1m
Net debt
positive
Cash
$42.8m
Shares outstanding
39.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 0.9
EV/Sales
1.1 | 0.9
EV/FCF
negative
P/B
4.5
Financial Health
Equity Ratio
32.9%
Return on Equity
-133.0%
ROCE
-65.5%
ROIC
-
Debt/Equity
2.3
Financials (TTM | estimate)
Revenue
$71.2m | $87.8m
EBITDA
$-38.7m | $-18.5m
EBIT
$-39.8m | $-28.8m
Net Income
$-43.4m | $-28.7m
Free Cash Flow
$-37.7m
Growth (TTM | estimate)
Revenue
12.8% | 26.7%
EBITDA
12.8% | 54.4%
EBIT
12.1%
Net Income
-7.8% | 24.2%
Free Cash Flow
15.3%
Margin (TTM | estimate)
Gross
66.9%
EBITDA
-54.4% | -21.1%
EBIT
-55.8%
Net
-61.0% | -32.7%
Free Cash Flow
-52.9%
More
EPS
$-1.0
FCF per Share
$-1.0
Short interest
1.8%
Employees
209
Rev per Employee
$330.0k
Show more

Is TELA Bio Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

TELA Bio Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a TELA Bio Inc forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a TELA Bio Inc forecast:

Buy
82%
Hold
18%

Financial data from TELA Bio Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
71 71
13% 13%
100%
- Direct Costs 24 24
20% 20%
33%
48 48
9% 9%
67%
- Selling and Administrative Expenses 78 78
0% 0%
110%
- Research and Development Expense 8.96 8.96
10% 10%
13%
-39 -39
13% 13%
-54%
- Depreciation and Amortization 1.05 1.05
28% 28%
1%
EBIT (Operating Income) EBIT -40 -40
12% 12%
-56%
Net Profit -43 -43
8% 8%
-61%

In millions USD.

Don't miss a Thing! We will send you all news about TELA Bio Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

TELA Bio Inc Stock News

Neutral
GlobeNewsWire
30 days ago
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TE...
Neutral
GlobeNewsWire
about one month ago
Based on market research, inguinal hernia repair is the most common type of hernia repair Based on market research, inguinal hernia repair is the most common type of hernia repair
Neutral
GlobeNewsWire
about one month ago
Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth
More TELA Bio Inc News

Company Profile

TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Head office United States
CEO Antony Koblish
Employees 209
Founded 2012
Website www.telabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today